NLS Pharmaceutics Competitors and Similar CompaniesClear all

NLS Pharmaceutics's competitors and similar companies include ACADIA Pharmaceuticals.
NLS Pharmaceutics
NLS Pharmaceutics
NLS Pharmaceutics is a biopharmaceutical company engaged in drug discovery for central nervous system disorders.
ACADIA Pharmaceuticals
ACADIA Pharmaceuticals
ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders.
Founding Date
Founding Date
2019
Founding Date
1993
Type
Type
Public
Type
Public
Tags
Locations
Locations
Stans, CH HQ
Locations
San Diego, US HQ
Princeton, US
Employees
Employees
6
Employees
513
Valuation ($)
Valuation ($)
10.2 m
Valuation ($)
2.4 b

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$1.1b (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
$89m (FY, 2025)
Gross profit
Gross profit
$2.5m (FY, 2024)
Gross profit
$982.5m (FY, 2025)
Net income
Net income
($2m) (FY, 2024)
Net income
$391m (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

ACADIA Pharmaceuticals
HQ
San Diego, US
Employees
513

ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders.

View company